SMMT
Summit Therapeutics Inc Earnings
$21.75
Earnings Summary
Revenue | $0Mn |
Net Profits | $-565.71Mn |
Net Profit Margins | -Inf% |
Summit Therapeutics Inc’s revenue jumped NaN% since last year same period to $0Mn in the Q2 2025. On a quarterly growth basis, Summit Therapeutics Inc has generated NaN% jump in its revenue since last 3-months.
Summit Therapeutics Inc’s net profit fell -836.84% since last year same period to $-565.71Mn in the Q2 2025. On a quarterly growth basis, Summit Therapeutics Inc has generated -799.19% fall in its net profits since last 3-months.
Summit Therapeutics Inc’s net profit margin jumped NaN% since last year same period to -Inf% in the Q2 2025. On a quarterly growth basis, Summit Therapeutics Inc has generated NaN% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -0.1 |
EPS Estimate Current Year | -0.1 |
Summit Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.1 - a -14.67% fall from last quarter’s estimates.
Summit Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -0.1.
Key Ratios
Earning Per Share (EPS) | -0.12 |
Summit Therapeutics Inc’s earning per share (EPS) fell -33.33% since last year same period to -0.12 in the Q2 2025. This indicates that the Summit Therapeutics Inc has generated -33.33% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-05-01 | -0.07 | -0.07 | 0.73% |
2025-08-11 | -0.09 | -0.12 | -33.33% |
